last updated:
October 8, 2025
min read
Allara Health Expands Nationally and Reports Significant Clinical Outcomes in Women’s Hormonal and Metabolic Health
Hormonal and Metabolic Health Impact Report
Women’s healthcare provider also expands to all 50 states, as it shows strong clinical improvements and cost savings for patients with complex conditions like PCOS, obesity and fertility challenges
NEW YORK, NY – October 8, 2025 – Allara Health, an integrated women’s health provider specializing in expert, longitudinal care that supports women through every life stage, today announced new clinical outcomes data that demonstrate significant improvements in patient outcomes and reduced costs of care. Published in Allara’s Hormonal and Metabolic Health 2025 Impact Report, the findings underscore the provider’s commitment to filling critical gaps in care for women and building a new standard of multidisciplinary women’s healthcare.
Allara’s report comes as the company also announced its expansion to support women in all 50 states.
The Hormonal and Metabolic Health 2025 Impact Report included an analysis of nearly 1,500 patients, and in just the first nine months of care, Allara’s integrated model delivered:
- A 5% mean BMI reduction among patients with BMI >30;
- 9% HbA1c reduction in patients with HbA1c > 6;
- 12% reduction in insulin resistance for patients with HOMA-IR >4.0.
“Allara was founded to close the long-overlooked gaps in women’s health, especially for those navigating hormonal and metabolic conditions that affect every aspect of life,” said Rachel Blank, Founder of Allara Health. “These results validate that when women are given access to coordinated, multidisciplinary care early in life, we can improve outcomes, improve quality of life and prevent costly chronic conditions later on.”
More than one-in-three women live with conditions such as PCOS, endometriosis or thyroid disorders, yet these conditions remain underdiagnosed, undertreated and care is fragmented. These hormonal conditions are also deeply interrelated with broader metabolic health, influencing risks such as insulin resistance, obesity and cardiometabolic disease, often creating challenges for future fertility and healthy pregnancies. As a result, affected women are significantly more likely to experience infertility and pregnancy complications, future cardiometabolic diseases, as well as have increased rates of depression and anxiety. Allara addresses the gaps that exist in the traditional care environment through its national, consumer-first model that pairs each patient with a multidisciplinary team – including OBGYN providers, endocrinologists, registered dietitians and patient success leads – who deliver integrated, whole-body care. Since launch, Allara has treated more than 40,000 women nationwide, making it among the largest providers focused specifically on women’s hormonal, metabolic and reproductive health.
Additionally, 69% of Allara patients who previously experienced irregular menstrual cycles reported improved menstrual regularity, and many also reported meaningful improvements in daily life. Nearly 9 in 10 said they felt supported in making positive health changes, with the majority also reporting improvements to both diet (78%) and exercise habits (56%). Patients additionally described broader life impacts, with 84% noting improved productivity at work and 96% saying the program was helpful in fertility planning and support.
The clinical outcomes together with the patient experience and engagement metrics demonstrate that Allara has the potential to deliver significant cost savings. Based on internal modeling, Allara’s care approach is estimated to save more than $3,000 per patient annually. The savings come from avoiding diabetes-related costs, obesity-related complications and fertility-related expenses, demonstrating the dual impact of improved patient health and reduced financial burden for payers, employers and the broader healthcare system.
In January, Allara raised $26 million in its Series B funding round to support its expansion of care across all 50 U.S. states, enhance its clinical leadership and deepen insurance partnerships with national health plans. The investment also enabled Allara to scale its multidisciplinary care model, build stronger partnerships and increase access for the tens of millions of women in need of better support.
About Allara Health
Allara is a comprehensive women’s health provider that specializes in expert, longitudinal care that supports women through every life stage. Trusted by over 40,000 women nationwide, Allara makes expert healthcare accessible by connecting patients with multidisciplinary care teams that have a deep understanding of hormonal, metabolic and reproductive care. Allara provides ongoing support for hormonal conditions like PCOS, chronic conditions like insulin resistance and life stages like perimenopause, helping patients see improved health outcomes and achieve their individualized goals. To learn more about Allara, visit www.allarahealth.com.
###
“I was given an explanation of how my hormonal imbalance was affecting me as a whole - body & mind - & tools so that we could start to manage my condition. I am happy to announce after a year of trying, I found out that I was pregnant & I couldn’t be happier!”
“This is genuinely the first time in my 7 years of being diagnosed, that I have felt seen and heard.”
“The Allara Community gives me the courage and support to continue my PCOS journey - I am never afraid to ask the hard questions and love hearing from other women with the same challenges.”
"My doctor went above and beyond making sure I had all the necessary tests, but also tremendously helped me in understanding my diagnosis, helping me change my lifestyle, and making sure I get the treatment I deserve."
"Before Allara I had no real direction or understanding of what it meant to have PCOS. Now I have a team of people that take time to explain every single thing to me, ask me how I feel and let me be apart of my treatment plan and I’ve lost 55 pounds."
